ALI/ARDS Clinical Sub-phenotyping Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChina-Japan Friendship Hospital
About this trial
1. Construct a structured clinical data and biosample information platform for Chinese patients with acute lung injury/ acute respiratory distress syndrome. 2. By deciphering the heterogeneity of patients with acute lung injury/ acute respiratory distress syndrome, achieve clinical, longitudinal physiological, and biological sub-phenotyping to guide individualized precision treatment and improve prognosis.
Eligibility criteria
Qualifiers
Meet the diagnostic criteria for Acute Respiratory Distress Syndrome (ARDS) according to the updated global definition in 2023.
The patient or their legal representative signs an informed consent form.
Disqualifiers
Individuals aged less than 18 years old.
Those who refuse to participate in the study.
Trial design
Treatments tested in this trial
- Collect peripheral blood and bronchoalveolar lavage fluid
Treatment groups
No treatment groups listed
Locations
1Jingen Xia Beijing China
Sponsors and collaborators
China-Japan Friendship Hospital
Lead sponsor
Source ClinicalTrials.gov